ISB News

The Other Malaria: Finding New Targets for a Vaccine Against Plasmodium vivax

Warhol style Plasmodium

A new report in PLOS Neglected Tropical Diseases describes the results of an international collaboration led by researchers at ISB and Seattle’s Center for Infectious Disease Research (CIDResearch). We used mass spectrometry-based proteomics to identify nearly 2,000 proteins present in Plasmodium vivax parasites, one of the Plasmodium species that cause the disease malaria in humans. The work was done on parasites dissected from mosquito salivary glands, parasites that were in the form that is transmitted from mosquitoes to humans. Because parasite proteins can potentially be recognized by the body’s immune system, the proteins we have identified are promising targets for new vaccines against malaria.

Read More

Recent Articles

  • soldier

    ISB Researchers Seek a Better Way to Identify Chronic Mild Traumatic Brain Injury

    Mild traumatic brain injury (mTBI) has been a frequent injury among U.S. combatants, and blast-related mTBI has been called the “signature injury” from nearly two decades of military conflicts in Iraq and Afghanistan. ISB researchers are working to develop new methods to identify molecular changes in the blood of war veterans diagnosed with chronic mTBI.

  • Dr. Christian Diener, postdoc in ISB's Gibbons Lab.

    New Modeling Tool Allows Microbiome Researchers to Map Community Ecology to Ecosystem Function

    A promising new open-source metabolic modeling tool provides microbiome researchers a path forward in predicting ecosystem function from community structure. News of the software package, called MICOM, was developed in part by researchers in ISB’s Gibbons Lab, and its uses were published in the journal mSystems.

  • Dr. Jim Heath

    ISB Marking 20th Anniversary with Year-Long Celebration

    Letter from the president: Dr. Jim Heath announces the kickoff of a 2020 celebration marking ISB’s 20th anniversary. The year-long celebration will include an ISB-Town Hall Seattle speaker series focusing on some of the most important topics in science and health care.